“Relaxin-2”的搜索结果，显示 21-30 项，共有 7270 项
Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...
... 2 or 3 meningioma as measured by 6-month PFS rate. A Study of Demyelinating Lesions as a Cause of Progressive Motor Deterioration. Rochester, Minn. The ...
... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...
... 2 or 3 meningioma as measured by 6-month PFS rate. Mayo Clinic Cancer Center Neuro-Oncology Program Registry And Biobank For The Study Of Nervous System ...
This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...
... 2 or 3 meningioma as measured by 6-month PFS rate. A Study to Investigate Biomarkers for Phenotyping of Neurodegenerative Disorders. Jacksonville, Fla. The ...
... 2 or 3 meningioma as measured by 6-month PFS rate. A Study of Demyelinating ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) ...
... 2 or 3 meningioma as measured by 6-month PFS rate. Validation Of Early Prognostic Data For Recovery Outcome After Stroke For Future, Higher Yield Trials.
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。